Lori A. Macomber
EVP, CFO & TreasurerMs. Lori A. Macomber, C.P.A., serves as Chief Financial Officer, Executive Vice President and Treasurer of Karyopharm Therapeutics Inc. since January 3, 2025. She was Chief Financial Officer of Legend Biotech Corporation since May 09, 2022 until January 2, 2025, where she was responsible to lead the company's financial operations and retain her responsibilities for its principal financial and accounting officer. She joined Legend Biotech in March 2021. She is a highly valued leader and strategic thought partner that has been instrumental in building the company's finance organization. Since joining Legend Biotech in September 2019, she has served as Vice President of Finance and Vice President of Supply Chain Finance and Controller. Prior to Legend, Ms. Macomber was Business Unit Controller at Ametek PDS, a leading supplier of components and systems for the aerospace and defense industries. In her tenure as a finance specialist, Ms. Macomber also held various senior finance and accounting roles in the life sciences industry, including U.S. CFO and Controller of Cello Heath and AVP Finance Site Leader at Eli Lilly & Company. Ms. Macomber holds a Bachelor of Science in Accounting from Pennsylvania State University and is a certified public accountant.
Positions
- Company NameKaryopharm Therapeutics Inc.Stock CodeKPTIQPositionEVP, CFO & TreasurerColleagues
- RARichard A. PaulsonPresident, CEO & Director
- SPStuart PoultonExecutive VP & Chief Development Officer
- RRReshma RangwalaExecutive VP, Chief Medical Officer & Head of Research
- SSSharon ShachamCo-Founder & Chairman of Scientific Advisory Board
- BEBarry E. GreeneLead Independent Director
- DRDeepika Rachel PakianathanIndependent Director
- GGGaren G. BohlinIndependent Director
